Prions: Generation and spread versus neurotoxicity

Journal of Biological Chemistry

Volumn 289, Issue 29, 2014, Pages 19862-19868

  Halliday, Mark ^a   Radford, Helois ^a   Mallucci, Giovanna R ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEURODEGENERATIVE DISEASES;

INFECTIOUS AGENTS; MISFOLDED PROTEINS; NEURODEGENERATION; NEUROTOXICITY; PARKINSON DISEASE; PRION DISEASE; PROTEIN MISFOLDING; UNFOLDED PROTEIN RESPONSE;

PROTEINS;

ACTIVATING TRANSCRIPTION FACTOR 4; ALPHA SYNUCLEIN; BETA SYNUCLEIN; GAMMA SYNUCLEIN; GSK 2606414; INITIATION FACTOR 2ALPHA; LENTIVIRUS VECTOR; MESSENGER RNA; PRION PROTEIN; PROTEIN GADD34; PROTEIN KINASE; PROTEIN KINASE RNA LIKE ENDOPLASMIC RETICULUM KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TAU PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BIOACCUMULATION; COGNITIVE DEFECT; DRUG STRUCTURE; DRUG TARGETING; GENE EXPRESSION; GENE SILENCING; GENETIC MANIPULATION; HUMAN; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARKINSON DISEASE; PRION; PRION DISEASE; PRIORITY JOURNAL; PRNP GENE; PROTEIN DEFECT; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEIN TARGETING; PROTEIN UNFOLDING; RNA INTERFERENCE; SHORT SURVEY; VIRUS REPLICATION;

ALZHEIMER DISEASE; ALZHEIMER'S; GENE THERAPY; NEURODEGENERATION; NEUROPROTECTION; PRION; UNFOLDED PROTEIN RESPONSE (UPR);

ADENINE; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; EIF-2 KINASE; HUMANS; INDOLES; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; PRION DISEASES; PRIONS; PROTEIN CONFORMATION; PROTEIN KINASE INHIBITORS; TAU PROTEINS; TAUOPATHIES; UNFOLDED PROTEIN RESPONSE;

EID: 84904497398     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R114.568477     Document Type: Short Survey

References (54)

1. Prusiner, S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144
2. Griffith, J. S. (1967) Self-replication and scrapie. Nature 215, 1043-1044
3. McKinley, M. P., Bolton, D. C., and Prusiner, S. B. (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 57-62 (Pubitemid 14240218)
4. Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, S. B., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-746 (Pubitemid 15240279)
5. Chesebro, B., Race, R., Wehrly, K., Nishio, J., Bloom, M., Lechner, D., Bergstrom, S., Robbins, K., Mayer, L., Keith, J. M., et al. (1985) Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315, 331-333 (Pubitemid 15044624)
6. Prusiner, S. B. (1989) Creutzfeldt-Jakob disease and scrapie prions. Alzheimer Dis. Assoc. Disord. 3, 52-78
7. Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W. M., Mattson, M. P., and Tycko, R. (2005) Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307, 262-265 (Pubitemid 40116242)
8. Desplats, P., Lee, H. J., Bae, E. J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., and Lee, S. J. (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proc. Natl. Acad. Sci. U.S.A. 106, 13010-13015
9. Frost, B., Jacks, R. L., and Diamond, M. I. (2009) Propagation of Tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 284, 12845-12852
10. Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., Jucker, M., Goedert, M., and Tolnay, M. (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909-913
11. Jucker, M., and Walker, L. C. (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann. Neurol. 70, 532-540
12. Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O'Brien, P., Trojanowski, J. Q., and Lee, V. M. (2012) Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949-953
13. Mougenot, A. L., Nicot, S., Bencsik, A., Morignat, E., Verchère, J., Lakhdar, L., Legastelois, S., and Baron, T. (2012) Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol. Aging 33, 2225-2228
14. Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai, T., Akiyama, H., Mann, D. M., and Hasegawa, M. (2013) Prion-like spreading of pathological α-synuclein in brain. Brain 136, 1128-1138
15. Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P. C., Brandner, S., and Collinge, J. (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874 (Pubitemid 37339628)
16. Hill, A. F., and Collinge, J. (2003) Subclinical prion infection in humans and animals. Br. Med. Bull. 66, 161-170 (Pubitemid 37173500)
17. Sandberg, M. K., Al-Doujaily, H., Sharps, B., Clarke, A. R., and Collinge, J. (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470, 540-542
18. Büeler, H., Aguzzi, A., Sailer, A., Greiner, R. A., Autenried, P., Aguet, M., and Weissmann, C. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347 (Pubitemid 23201147)
19. Manson, J. C., Clarke, A. R., Hooper, M. L., Aitchison, L., McConnell, I., and Hope, J. (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8, 121-127
20. Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., and Aguzzi, A. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343 (Pubitemid 26033075)
21. Frigg, R., Klein, M. A., Hegyi, I., Zinkernagel, R. M., and Aguzzi, A. (1999) Scrapie pathogenesis in subclinically infected B-cell-deficient mice. J. Virol. 73, 9584-9588 (Pubitemid 29487114)
22. Thackray, A. M., Klein, M. A., Aguzzi, A., and Bujdoso, R. (2002) Chronic subclinical prion disease induced by low-dose inoculum. J. Virol. 76, 2510-2517 (Pubitemid 34150719)
23. Thackray, A. M., Klein, M. A., and Bujdoso, R. (2003) Subclinical prion disease induced by oral inoculation. J. Virol. 77, 7991-7998 (Pubitemid 36792795)
24. Collinge, J., Owen, F., Poulter, M., Leach, M., Crow, T. J., Rossor, M. N., Hardy, J., Mullan, M. J., Janota, I., and Lantos, P. L. (1990) Prion dementia without characteristic pathology. Lancet 336, 7-9 (Pubitemid 20207867)
25. Medori, R., Tritschler, H. J., LeBlanc, A., Villare, F., Manetto, V., Chen, H. Y., Xue, R., Leal, S., Montagna, P., Cortelli, P., et al. (1992) Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N. Engl. J. Med. 326, 444-449
26. Hsiao, K. K., Scott, M., Foster, D., Groth, D. F., DeArmond, S. J., and Prusiner, S. B. (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250, 1587-1590 (Pubitemid 120034374)
27. Mallucci, G. R., White, M. D., Farmer, M., Dickinson, A., Khatun, H., Powell, A. D., Brandner, S., Jefferys, J. G. R., and Collinge, J. (2007) Targeting cellular prion protein reverses early coanitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53, 325-335 (Pubitemid 46161264)
28. White, M. D., Farmer, M., Mirabile, I., Brandner, S., Collinge, J., and Mallucci, G. R. (2008) Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc. Natl. Acad. Sci. U.S.A. 105, 10238-10243
29. Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., LaCasse, R., Raymond, L., Favara, C., Baron, G., Priola, S., Caughey, B., Masliah, E., and Oldstone, M. (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435-1439 (Pubitemid 40791292)
30. Watts, J. C., Giles, K., Oehler, A., Middleton, L., Dexter, D. T., Gentleman, S. M., DeArmond, S. J., and Prusiner, S. B. (2013) Transmission of multiple system atrophy prions to transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 110, 19555-19560
31. Mallucci, G. R., Ratté, S., Asante, E. A., Linehan, J., Gowland, I., Jefferys, J. G. R., and Collinge, J. (2002) Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J. 21, 202-210 (Pubitemid 34137282)
32. Moreno, J. A., Halliday, M., Molloy, C., Radford, H., Verity, N., Axten, J. M., Ortori, C. A., Willis, A. E., Fischer, P. M., Barrett, D. A., and Mallucci, G. R. (2013) Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med. 5, 206ra138
33. Moreno, J. A., Radford, H., Peretti, D., Steinert, J. R., Verity, N., Martin, M. G., Halliday, M., Morgan, J., Dinsdale, D., Ortori, C. A., Barrett, D. A., Tsaytler, P., Bertolotti, A., Willis, A. E., Bushell, M., and Mallucci, G. R. (2012) Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature 485, 507-511
34. Andre, R., and Tabrizi, S. J. (2012) Misfolded PrP and a novel mechanism of proteasome inhibition. Prion 6, 32-36
35. Ron, D., and Walter, P. (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519-529 (Pubitemid 46985379)
36. Met is an important translation initiation intermediate in vivo. Genes Dev. 14, 2534-2546
37. Novoa, I., Zeng, H., Harding, H. P., and Ron, D. (2001) Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α. J. Cell Biol. 153, 1011-1022
38. Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., and Ron, D. (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6, 1099-1108
39. Axten, J. M., Medina, J. R., Feng, Y., Shu, A., Romeril, S. P., Grant, S. W., Li, W. H., Heerding, D. A., Minthorn, E., Mencken, T., Atkins, C., Liu, Q., Rabindran, S., Kumar, R., Hong, X., Goetz, A., Stanley, T., Taylor, J. D., Sigethy, S. D., Tomberlin, G. H., Hassell, A. M., Kahler, K. M., Shewchuk, L. M., and Gampe, R. T. (2012) Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl) phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J. Med. Chem. 55, 7193-7207
40. Kober, L., Zehe, C., and Bode, J. (2012) Development of a novel ER stress based selection system for the isolation of highly productive clones. Biotechnol. Bioeng. 109, 2599-2611
41. Hoozemans, J. J., van Haastert, E. S., Eikelenboom, P., de Vos, R. A., Rozemuller, J. M., and Scheper, W. (2007) Activation of the unfolded protein response in Parkinson's disease. Biochem. Biophys. Res. Commun. 354, 707-711 (Pubitemid 46186242)
42. Hoozemans, J. J., van Haastert, E. S., Nijholt, D. A., Rozemuller, A. J., Eikelenboom, P., and Scheper, W. (2009) The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am. J. Pathol. 174, 1241-1251
43. Hoozemans, J. J., Veerhuis, R., Van Haastert, E. S., Rozemuller, J. M., Baas, F., Eikelenboom, P., and Scheper, W. (2005) The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol. 110, 165-172 (Pubitemid 41245205)
44. Unterberger, U., Höftberger, R., Gelpi, E., Flicker, H., Budka, H., and Voigtländer, T. (2006) Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J. Neuropathol. Exp. Neurol. 65, 348-357 (Pubitemid 44264832)
45. Stutzbach, L. D., Xie, S. X., Naj, A. C., Albin, R., Gilman, S., PSP Genetics Study Group, Lee, V. M., Trojanowski, J. Q., Devlin, B., and Schellenberg, G. D. (2013) The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathol. Commun. 1, 31
46. Höglinger, G. U., Melhem, N. M., Dickson, D. W., Sleiman, P. M., Wang, L. S., Klei, L., Rademakers, R., de Silva, R., Litvan, I., Riley, D. E., van Swieten, J. C., Heutink, P., Wszolek, Z. K., Uitti, R. J., Vandrovcova, J., Hurtig, H. I., Gross, R. G., Maetzler, W., Goldwurm, S., Tolosa, E., Borroni, B., Pastor, P., PSP Genetics Study Group, Cantwell, L. B., Han, M. R., Dillman, A., van der Brug, M. P., Gibbs, J. R., Cookson, M. R., Hernandez, D. G., Singleton, A. B., Farrer, M. J., Yu, C. E., Golbe, L. I., Revesz, T., Hardy, J., Lees, A. J., Devlin, B., Hakonarson, H., Müller, U., and Schellenberg, G. D. (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat. Genet. 43, 699-705
47. Costa-Mattioli, M., Gobert, D., Stern, E., Gamache, K., Colina, R., Cuello, C., Sossin, W., Kaufman, R., Pelletier, J., Rosenblum, K., Krnjević, K., Lacaille, J. C., Nader, K., and Sonenberg, N. (2007) eIF2α phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell 129, 195-206 (Pubitemid 46507591)
48. Sidrauski, C., Acosta-Alvear, D., Khoutorsky, A., Vedantham, P., Hearn, B. R., Li, H., Gamache, K., Gallagher, C. M., Ang, K. K. H., Wilson, C., Okreglak, V., Ashkenazi, A., Hann, B., Nader, K., Arkin, M. R., Renslo, A. R., Sonenberg, N., and Walter, P. (2013) Pharmacological brake-release of mRNA translation enhances cognitive memory. Elife 2, e00498
49. Ma, T., Trinh, M. A., Wexler, A. J., Bourbon, C., Gatti, E., Pierre, P., Cavener, D. R., and Klann, E. (2013) Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nat. Neurosci. 16, 1299-1305
50. Kim, H. J., Raphael, A. R., LaDow, E. S., McGurk, L., Weber, R. A., Trojanowski, J. Q., Lee, V. M., Finkbeiner, S., Gitler, A. D., and Bonini, N. M. (2014) Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 46, 152-160
51. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489 (Pubitemid 36444329)
52. de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., Spires-Jones, T. L., and Hyman, B. T. (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73, 685-697
53. Watts, J. C., and Prusiner, S. B. (2014) Mouse models for studying the formation and propagation of prions. J. Biol. Chem. 289, 19841-19849
54. Holmes, B. B., and Diamond, M. I. (2014) Prion-like properties of Tau protein: the importance of extracellular tau as a therapeutic target. J. Biol. Chem. 289, 19855-19861